Results 41 to 50 of about 4,202,888 (305)
Therapeutic Apheresis and Dialysis, EarlyView.ABSTRACT Background Chronic kidney disease is a growing public health problem worldwide, and the number of patients requiring renal replacement therapy is steadily increasing. Türkiye has experienced a similar rise in both the incidence and prevalence of renal replacement therapy over the past decades; however, national‐level projections of future ...
Arzu Akgül +2 more
wiley +1 more source
Science in non-hegemonic countries
Revue d'anthropologie des connaissances, 2008 What does non-hegemonic country mean? This dossier was indeed intended to deal with knowledge in “developing” countries. However, it tries to avoid the conventional enumeration of stigmas (poverty, illiteracy, epidemics, low investment and infrastructure,
Philippe Losego, Rigas Arvanitis
doaj +1 more source
Molecular Oncology, EarlyView.PARP inhibitors are used to treat a small subset of prostate cancer patients. These studies reveal that PARP1 activity and expression are different between European American and African American prostate cancer tissue samples. Additionally, different PARP inhibitors cause unique and overlapping transcriptional changes, notably, p53 pathway upregulation.
Moriah L. Cunningham +21 more
wiley +1 more source
How has neoliberalism weakened science?
Natures Sciences Sociétés, 2021 The current Covid-19 pandemic, and before that, the environmental crisis due to climate change, raise major questions about the relationship between science and society.
Davi Hendrik +3 more
doaj +1 more source
The rhetoric of “science diplomacy": Innovation for the EU's scientific cooperation? EL-CSID Working Paper Issue 2018/16 • April 2018 [PDF]
, 2018 In the recent years, the EU policy discourse has endorsed the notion of “science diplomacy” that points to the interaction between scientific research and foreign policy as instrumental in the societal and political progress.
Penca, Jerneja
core
Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology
Molecular Oncology, EarlyView.Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts +8 more
wiley +1 more source
What do I make of your Latinorum? Sensitivity auditing of mathematical modelling
, 2012 In their book Uncertainty and Quality of Science for Policy (1990), Funtowicz and Ravetz argued the need to extend traditional methods and techniques of quality assurance in policy-related science.
Funtowicz, Silvio +3 more
core +1 more source
Molecular Oncology, EarlyView.Genetic testing in epithelial ovarian cancer includes both germline and tumor‐testing. This approach often duplicates resources. The current prospective study assessed the feasibility of tumor‐first multigene testing by comparing tumor tissue with germline testing of peripheral blood using an 18‐gene NGS panel in 106 patients.
Elisabeth Spenard +12 more
wiley +1 more source
Foresight and STI Governance, 2017 This paper studies the Russian Science Foundation’s first grant competition, which was held in 2014 to select exploratory or basic research projects, in order to shed light on the following two questions: (1) who wins the grants, and (2) what factors ...
Yuri Simachev +2 more
doaj +1 more source
Publications, 2023 Open access (OA) has become a critical issue in science policy and affects a wide range of activities in universities and research labs. Research-performing organizations (RPOs), defined as publicly funded universities and research institutions, face ...
Heinz Pampel
doaj +1 more source